The optimal neoadjuvant regimen for nonsmall cell lung cancer: A meta-analysis

To compare the efficacy and complications of different neoadjuvant to determine the optimal regimens for nonsmall cell lung cancer (NSCLC) patients. METHODS: A systematic search of the Web of Science, and PubMed databases was conducted through June 3, 2021, reporting a comparison of chemotherapy, ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yi, Zhao, Chong, Lu, Qiuliang, Hu, Yirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410656/
https://www.ncbi.nlm.nih.gov/pubmed/36042672
http://dx.doi.org/10.1097/MD.0000000000030159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410656/
https://www.ncbi.nlm.nih.gov/pubmed/36042672
http://dx.doi.org/10.1097/MD.0000000000030159

Ejemplares similares